The expression of Nectin-4 on the surface of ovarian cancer tumors [17–19] suggests that Nectin-4 is a valid target for therapy, and our in vitro data showed that a mAb against the IgV domain of Nectin-4 almost completely blocked ovarian cancer cell adhesion to Nectin-1. Here, NECTIN1 is linked to ovarian carcinoma.